Diabetes

Global Gaps in Diabetes Technology, Insulin Linked to Poor Outcomes

September 2nd 2025

Weekly mobile messages improved blood sugar, blood pressure, and heart health risk management in patients with type 2 diabetes (T2D), a study finds.

Gaps Exist in Diabetic Retinopathy Screening Knowledge Among Providers, Study Finds

August 27th 2025

Woman with vision problem | Image credit: Jo Panuwat D - stock.adobe.com

METS-IR Predicts Cardiovascular Risk in Type 2 Diabetes

August 26th 2025

Semaglutide, Tirzepatide Linked to Small Increase in Eye Disorder Risk

August 22nd 2025

eye health in a clinical setting-Microgen-stock.adobe.com

1 Credit / Cardiology, Neurology

August 18th 2025

Advancing Care in Type 2 Diabetes and Obesity: A Coordinated, Guideline-Driven Approach

Understand how recent advances in GLP-1 receptor agonists and other therapies are transforming the treatment of type 2 diabetes and obesity through a shift of reactive to proactive care that addresses root causes of cardiometabolic disease.

Watch Now

Continuing Medical Education

View All

September 5th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

September 5th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

December 3rd 2015

ELIXA Results on Lixisenatide Published in NEJM

Results first presented at the American Diabetes Association in June are published. The new drug application has since been filed at FDA.

December 2nd 2015

National Quality Forum Comment Period on Measures to Review Still Open

This year's measures include 60 that will be part of the new Merit-Based Incentive Payment System or MIPS, which was created under legislation that eliminated the Sustainable Growth Rate.

December 2nd 2015

Under Pressure, Coca-Cola Backed Research Group Fizzles

Critics of the Global Energy Balance Network had compared its work to the tactics of big tobacco, which decades ago had sponsored studies to dissuade Americans that cigarettes were dangerous.

December 1st 2015

After Several Clues, CDC Confirms Drop in New Diabetes Cases

Despite the good news, experts warn against being complacent, because new cases are still high among minorities and those with little education.

November 30th 2015

Pharmaceutical Advertising Increased Prescription Drug Utilization, Study Reports

Surabhi Dangi-Garimella, PhD

Relaxed direct-to-consumer advertising restrictions for drugs by the FDA in 1997 has precipitated an increase in prescription drug utilization, not just among Medicare enrollees, but also among non-elderly users.

November 30th 2015

Testosterone Therapy Could Help Men With Type 2 Diabetes

The link between low testosterone and decreased insulin sensitivity had been shown in previous research.

November 27th 2015

Top 5 Diabetes Stories for the Year

Diabetes is a growing epidemic in the United States and new research has indicated that half of healthy 45-year-olds will develop pre-diabetes and one-third will develop diabetes at some point.

November 27th 2015

American College of Physicians Recommends More Use of Generic Medications

Surabhi Dangi-Garimella, PhD

The American College of Physicians has published a paper in the Annals of Internal Medicine that advices clinicians to prescribe generic drugs whenever possible.

November 25th 2015

Mississippi to Pay for Bariatric Surgery to Combat Obesity

The policy change is aimed at curbing the state's obesity rate as well as comorbidities such as diabetes

November 25th 2015

What We're Reading: Coke Interfered With Work of Anti-Obesity Group

What we're reading, November 25, 2015: UnitedHealthcare's decision on healthcare exchange participation, Democratic Presidential candidate's health plan, and conflict of interest between soda company and anti-obesity research group.

November 25th 2015

Could Patiromer Change the Face of Treatment for Patients With Diabetic Renal Disease?

Erin Drewniany

A newly approved therapy offers the first new option in years to prevent hyperkalemia.

November 24th 2015

What We're Reading: Treating Earlier With Pricey HCV Drugs

What we're reading, November 24, 2015: expensive hepatitis C drugs are more cost effective when used earlier; clinicians aren't prescribing generics enough; and half of health 45-year-olds will develop prediabetes.

November 24th 2015

CVS Strikes Deal for Repatha Only; 18,000 Enroll in Long-term Praluent CV Outcomes Trial

Terms of the deal with the second-largest pharmacy benefit manager were not disclosed. Pricing for the PCSK9 inhibitor class has been a source of controversy since the cholesterol-fighting drugs were approved this summer.

November 23rd 2015

Preventive Care: Localized Efforts Can Deliver Outsized Results

Brenda Schmidt

Community-based organizations are ideally suited for healthcare prevention efforts and provide a needed linkage to medical care provider systems.

November 23rd 2015

Good News in Diabetes Care: Amputations Are Way Down Since 1990s

The study credited better drugs and improvements in foot inspections and self-care with the reduction.

November 23rd 2015

Louisiana's Governor-elect Makes Plans for Medicaid Expansion

John Bel Edwards was elected Governor of Louisiana Saturday after promising to expand Medicaid. Hospitals have been eager to see expansion; in the spring, they supported a fee to pay the state's share once the federal government stops paying 100% of expansion costs.

November 22nd 2015

Big Questions About Diabetes Lead to Answers From Those Who Have Lived With Disease the Longest

Andrew Smith

An Interview with Joslin's George King, MD

November 20th 2015

It's Not Always Coverage-Social Factors, Barriers Can Keep Heart Failure Patients From Exercising

The findings suggest that addressing heart patients' social needs is the first step toward getting them to exercise more.

November 20th 2015

Using Sequence Discovery to Target Outreach for Diabetes Medication Adherence

April Lopez, MS Charron Long, PharmD Laura E. Happe, PharmD, MPH Michael Relish, MS

Sequence discovery techniques identified sequences of events that led to gaps in diabetic therapies and were used to identify outreach opportunities aimed at improving medication adherence.

November 19th 2015

Study in Circulation Identifies 10 Biomarkers That Predict CV Events

The study population took part in the landmark ORIGIN trial, which evaluated hypoglycemia effects in persons with high CV risk and diabetes.

November 18th 2015

Amgen's Repatha Gets Early Thumbs Down by Britain's NICE

The action by NICE highlights discussion on both sides of the Atlantic about the cost of PCSK9 inhibitors, which lower LDL cholesterol.

November 18th 2015

Community as Part of the Prescription: Social Media in Diabetes Care

Kerri Sparling Amy Tenderich, MA Hope Warshaw, MMSc, RD, CDE

This commentary was adapted from an appearance by the authors at Patient-Centered Diabetes Care, a conference jointly presented by The American Journal of Managed Care and Joslin Diabetes Center.

November 17th 2015

FDA Regulation of LDTs: A Report Justifies the Need for It

Surabhi Dangi-Garimella, PhD

It is time to regulate laboratory-developed tests that cost Medicare $9.7 billion in the year 2012 alone.

November 16th 2015

Study Shows Need for Benefits in Kentucky, Where They May Wither

The study suggests treating depression could help combating poor diet and obesity. But in Kentucky, the future of Medicaid expansion is in doubt following the recent election.

November 16th 2015

Can SGLT2 Inhibitors Offer Options for Type 1 Treatment?

Andrew Smith

Several clinical trials under way are examining whether a new class of therapy approved to treat type 2 diabetes can also treat type 1.

November 16th 2015

JAMA Study on DR Treatment Says Anti-VEGF Agent "Noninferior" for Long-Term Use

The VEGF inhibitors have been a game-changer in treatment of ocular conditions in diabetes.

November 15th 2015

Is It Possible to Prevent or Delay Type 1 Diabetes?

Sejal Saraiya, PharmD

A partnership between JDRF and Janssen Pharmaceuticals seeks ways to intercept the disease before it progresses.

November 15th 2015

US Employee Wellness Programs and Access to Obesity Treatment in Employer-Sponsored Health Insurance

Theodore K. Kyle, RPh, MBA Joseph F. Nadglowski Mechelle D. Claridy, MPH Fatima Cody Stanford, MD, MPH, MPA

Employer policies for access to maximum benefits do not always match those for access to obesity therapy.

November 13th 2015

Diabetes Management: An Age-Old Problem That Needs A Modern-Day Solution

Francois Nicolas, PhD

Sanofi's vice president of Diabetes Integrated Care discusses the recent collaboration with Google.

November 12th 2015

In New Jersey, Horizon BCBS, Catholic Hospital Huddle With Judge Over OMNIA